Liu, L. et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 388, 3027–3035 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Ku, L. C., Boggess, K. A. & Cohen-Wolkowiez, M. Bacterial meningitis in infants. Clin. Perinatol. 42, 29–45 (2015).

Article  PubMed  Google Scholar 

Furyk, J. S., Swann, O. & Molyneux, E. Systematic review: neonatal meningitis in the developing world. Trop. Med Int Health 16, 672–679 (2011).

Article  CAS  PubMed  Google Scholar 

Cantey, J. B. & Milstone, A. M. Bloodstream infections: epidemiology and resistance. Clin. Perinatol. 42, 1–16 (2015).

Article  PubMed  Google Scholar 

Anderson, V., Anderson, P., Grimwood, K. & Nolan, T. Cognitive and executive function 12 years after childhood bacterial meningitis: Effect of acute neurologic complications and age of onset. J. Pediatr. Psychol. 29, 67–81 (2004).

Article  PubMed  Google Scholar 

Evans-Roberts, K. M. et al. DNA gyrase is the target for the quinolone drug ciprofloxacin in Arabidopsis thaliana. J. Biol. Chem. 291, 3136–3144 (2016).

Article  CAS  PubMed  Google Scholar 

Sharma, D. et al. Interplay of the quality of ciprofloxacin and antibiotic resistance in developing countries. Front Pharm. 8, 546 (2017).

Article  Google Scholar 

Tebano, G. et al. Essential and forgotten antibiotics: An inventory in low- and middle-income countries. Int. J. Antimicrob. Agents 54, 273–282 (2019).

Article  CAS  PubMed  Google Scholar 

Nau, R., Sorgel, F. & Eiffert, H. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin. Microbiol Rev. 23, 858–883 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nau, R. et al. Penetration of ciprofloxacin into the cerebrospinal fluid of patients with uninflamed meninges. J. Antimicrob. Chemother. 25, 965–973 (1990).

Article  CAS  PubMed  Google Scholar 

Wolff, M. et al. Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis. Antimicrob. Agents Chemother. 31, 899–902 (1987).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lipman, J. et al. Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough? Intensive Care Med. 28, 493–500 (2002).

Article  CAS  PubMed  Google Scholar 

Rubio, T. T. et al. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation. Pediatr. Infect. Dis. J. 16, 112–117 (1997).

Article  CAS  PubMed  Google Scholar 

Dr Veronica Zanichelli, McMaster University. 2021 WHO Expert Committee on Selection and Use of Essential Medicines 2021. Available from: https://cdn.who.int/media/docs/default-source/essential-medicines/2021-eml-expert-committee/applications-for-new-indications-for-existing-listed-medicines/i.6_ab-neonatal-meningitis.pdf?sfvrsn=db6508d6_5.

Chaudhari, S., Suryawanshi, P., Ambardekar, S., Chinchwadkar, M. & Kinare, A. Safety profile of ciprofloxacin used for neonatal septicemia. Indian Pediatr. 41, 1246–1251 (2004).

PubMed  Google Scholar 

Dutta, S., Chowdhary, G., Kumar, P., Mukhopadhay, K. & Narang, A. Ciprofloxacin administration to very low birth weight babies has no effect on linear growth in infancy. J. Trop. Pediatr. 52, 103–106 (2006).

Article  PubMed  Google Scholar 

National Institute for Health and Care Excellance. Neonatal infection: antibiotics for prevention and treatment (2021). [Available from: https://www.nice.org.uk/guidance/ng195.

Zimmermann, P. & Curtis, N. Normal values for cerebrospinal fluid in neonates: A systematic review. Neonatology 118, 629–638 (2021).

Article  PubMed  Google Scholar 

Muchohi, S. N. et al. Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 879, 146–152 (2011).

Article  CAS  Google Scholar 

Zhao, W. et al. Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age. Antimicrob. Agents Chemother. 58, 6572–6580 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Baudry-Simner, P. J. et al. Mechanisms of reduced susceptibility to ciprofloxacin in Escherichia coli isolates from Canadian hospitals. Can. J. Infect. Dis. Med Microbiol 23, e60–e64 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Aggarwal, P., Dutta, S., Garg, S. K. & Narang, A. Multiple dose pharmacokinetics of ciprofloxacin in preterm babies. Indian Pediatr. 41, 1001–1007 (2004).

PubMed  Google Scholar 

Kaguelidou, F., Turner, M. A., Choonara, I. & Jacqz-Aigrain, E. Ciprofloxacin use in neonates: a systematic review of the literature. Pediatr. Infect. Dis. J. 30, e29–e37 (2011).

Article  PubMed  Google Scholar 

Hirt, D. et al. Population pharmacokinetics of intravenous and oral ciprofloxacin in children to optimize dosing regimens. Eur. J. Clin. Pharm. 77, 1687–1695 (2021).

Article  CAS  Google Scholar 

Pea, F., Viale, P., Pavan, F. & Furlanut, M. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin. Pharmacokinet. 46, 997–1038 (2007).

Article  CAS  PubMed  Google Scholar 

Facchin, A. et al. Variability of ciprofloxacin pharmacokinetics in children: impact on dose range in sickle cell patients. J. Antimicrob. Chemother. 73, 3423–3429 (2018).

Article  CAS  PubMed  Google Scholar